Autophagy suppresses Ras-driven epithelial tumourigenesis by limiting the accumulation of reactive oxygen species
Manent, J, Banerjee, S, de Matos Simoes, R, Zoranovic, T, Mitsiades, C, Penninger, J M, Simpson, K J, Humbert, P O, Richardson, H E
Published in Oncogene (05.10.2017)
Published in Oncogene (05.10.2017)
Get full text
Journal Article
The use of novel agents in the treatment of relapsed and refractory multiple myeloma
LAUBACH, J. P, MAHINDRA, A, MITSIADES, C. S, SCHLOSSMAN, R. L, MUNSHI, N. C, CHOBRIAL, I. M, CARREAU, N, HIDESHIMA, T, ANDERSON, K. C, RICHARDSON, P. G
Published in Leukemia (01.12.2009)
Published in Leukemia (01.12.2009)
Get full text
Journal Article
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib
Chauhan, Dharminder, Catley, Laurence, Li, Guilan, Podar, Klaus, Hideshima, Teru, Velankar, Mugdha, Mitsiades, Constantine, Mitsiades, Nicolas, Yasui, Hiroshi, Letai, Anthony, Ovaa, Huib, Berkers, Celia, Nicholson, Benjamin, Chao, Ta-Hsiang, Neuteboom, Saskia T.C., Richardson, Paul, Palladino, Michael A., Anderson, Kenneth C.
Published in Cancer cell (01.11.2005)
Published in Cancer cell (01.11.2005)
Get full text
Journal Article
Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma
BREITKREUTZ, I, RAAB, M. S, ANDERSON, K. C, VALLET, S, HIDESHIMA, T, RAJE, N, MITSIADES, C, CHAUHAN, D, OKAWA, Y, MUNSHI, N. C, RICHARDSON, P. G
Published in Leukemia (01.10.2008)
Published in Leukemia (01.10.2008)
Get full text
Journal Article
Antimyeloma activity of heat shock protein-90 inhibition
Mitsiades, Constantine S., Mitsiades, Nicholas S., McMullan, Ciaran J., Poulaki, Vassiliki, Kung, Andrew L., Davies, Faith E., Morgan, Gareth, Akiyama, Masaharu, Shringarpure, Reshma, Munshi, Nikhil C., Richardson, Paul G., Hideshima, Teru, Chauhan, Dharminder, Gu, Xuesong, Bailey, Charles, Joseph, Marie, Libermann, Towia A., Rosen, Neal S., Anderson, Kenneth C.
Published in Blood (01.02.2006)
Published in Blood (01.02.2006)
Get full text
Journal Article
Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignancies
Weisberg, Ellen, Nonami, Atsushi, Chen, Zhao, Liu, Feiyang, Zhang, Jianming, Sattler, Martin, Nelson, Erik, Cowens, Kristen, Christie, Amanda L, Mitsiades, Constantine, Wong, Kwok-Kin, Liu, Qingsong, Gray, Nathanael, Griffin, James D
Published in Leukemia (01.01.2015)
Published in Leukemia (01.01.2015)
Get full text
Journal Article
Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341
Hideshima, Teru, Mitsiades, Constantine, Akiyama, Masaharu, Hayashi, Toshiaki, Chauhan, Dharminder, Richardson, Paul, Schlossman, Robert, Podar, Klaus, Munshi, Nikhil C., Mitsiades, Nicholas, Anderson, Kenneth C.
Published in Blood (15.02.2003)
Published in Blood (15.02.2003)
Get full text
Journal Article
Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors and JAK inhibitors
WEISBERG, E, LIU, Q, MITSIADES, C, SMITH, R, DALEY, J. F, STONE, R, GALINSKY, I, GRIFFIN, J. D, GRAY, N, NELSON, E, KUNG, A. L, CHRISTIE, A. L, BRONSON, R, SATTLER, M, SANDA, T, ZHAO, Z, HUR, W
Published in Leukemia (01.10.2012)
Published in Leukemia (01.10.2012)
Get full text
Journal Article
Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma
Richardson, Paul G., Schlossman, Robert L., Weller, Edie, Hideshima, Teru, Mitsiades, Constantine, Davies, Faith, LeBlanc, Richard, Catley, Laurence P., Doss, Deborah, Kelly, Kathleen, McKenney, Mary, Mechlowicz, Julie, Freeman, Andrea, Deocampo, Reggie, Rich, Rebecca, Ryoo, Joan J., Chauhan, Dharminder, Balinski, Kathe, Zeldis, Jerome, Anderson, Kenneth C.
Published in Blood (01.11.2002)
Published in Blood (01.11.2002)
Get full text
Journal Article
Autophagy suppresses Ras-driven epithelial tumourigenesis by limiting the accumulation of reactive oxygen species
Manent, J, Banerjee, S, de Matos Simoes, R, Zoranovic, T, Mitsiades, C, Penninger, J M, Simpson, K J, Humbert, P O, Richardson, H E
Published in Oncogene (05.10.2017)
Published in Oncogene (05.10.2017)
Get full text
Journal Article
Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myeloma
RAJE, N, HIDESHIMA, T, KIZILTEPE, T, PODAR, K, OKAWA, Y, IKEDA, H, CARRASCO, R, RICHARDSON, P. G, CHAUHAN, D, MUNSHI, N. C, SHARMA, S, PARIKH, H, MUKHERJEE, S, CHABNER, B, SCADDEN, D, ANDERSON, K. C, RAAB, M, VALLET, S, CHHETRI, S, CIRSTEA, D, POZZI, S, MITSIADES, C, ROONEY, M
Published in Leukemia (01.05.2009)
Published in Leukemia (01.05.2009)
Get full text
Journal Article
Immunomodulatory drug costimulates T cells via the B7-CD28 pathway
LeBlanc, Richard, Hideshima, Teru, Catley, Laurence P., Shringarpure, Reshma, Burger, Renate, Mitsiades, Nicholas, Mitsiades, Constantine, Cheema, Puneet, Chauhan, Dharminder, Richardson, Paul G., Anderson, Kenneth C., Munshi, Nikhil C.
Published in Blood (01.03.2004)
Published in Blood (01.03.2004)
Get full text
Journal Article
TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications
Mitsiades, Constantine S., Treon, Steven P., Mitsiades, Nicholas, Shima, Yoshihito, Richardson, Paul, Schlossman, Robert, Hideshima, Teru, Anderson, Kenneth C.
Published in Blood (01.08.2001)
Published in Blood (01.08.2001)
Get full text
Journal Article
Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo
SHAMMAS, M. A, KOLE, H, ANDERSON, K. C, CHIN, A, GRYAZNOV, S, MUNSHI, N. C, BERTHEAU, R. C, NERI, P, FULCINITI, M, TASSONE, P, BLOTTA, S, PROTOPOPOV, A, MITSIADES, C, BATCHU, R. B
Published in Leukemia (01.07.2008)
Published in Leukemia (01.07.2008)
Get full text
Journal Article
P881: CDK7 CONTRIBUTES TO METABOLIC REPROGRAMMING IN MM CELLS THROUGH C‐MYC MEDIATED TRANSCRIPTIONAL CONTROL OF GLYCOLYTIC GENES
Yao, Y., Fong Ng, J., Park, W. D., Gramegna, D., Samur, A., Samur, M., Morelli, E., Chesi, M., Mitsiades, C., Anderson, K. C., Lin, C., Munshi, N., Fulciniti, M.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
Siegel, D S, Richardson, P, Dimopoulos, M, Moreau, P, Mitsiades, C, Weber, D, Houp, J, Gause, C, Vuocolo, S, Eid, J, Graef, T, Anderson, K C
Published in Blood cancer journal (New York) (21.02.2014)
Published in Blood cancer journal (New York) (21.02.2014)
Get full text
Journal Article
Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma
Raje, Noopur, Kumar, Shaji, Hideshima, Teru, Ishitsuka, Kenji, Chauhan, Dharminder, Mitsiades, Constantine, Podar, Klaus, Le Gouill, Steven, Richardson, Paul, Munshi, Nikhil C., Stirling, David I., Antin, Joseph H., Anderson, Kenneth C.
Published in Blood (15.12.2004)
Published in Blood (15.12.2004)
Get full text
Journal Article
Proteasome inhibition in the treatment of cancer
Richardson, Paul G, Mitsiades, Constantine, Hideshima, Teru, Anderson, Kenneth C
Published in Cell cycle (Georgetown, Tex.) (01.02.2005)
Get full text
Published in Cell cycle (Georgetown, Tex.) (01.02.2005)
Journal Article
Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors
Mitsiades, Constantine S, Mitsiades, Nicholas S, McMullan, Ciaran J, Poulaki, Vassiliki, Shringarpure, Reshma, Akiyama, Masaharu, Hideshima, Teru, Chauhan, Dharminder, Joseph, Marie, Libermann, Towia A, Garcı́a-Echeverrı́a, Carlos, Pearson, Mark A, Hofmann, Francesco, Anderson, Kenneth C, Kung, Andrew L
Published in Cancer cell (01.03.2004)
Published in Cancer cell (01.03.2004)
Get full text
Journal Article